Inventor · disambiguated record
Jinxu Wang
Also filed as: WANG JINXU
1 granted patent·7 pending applications·1 citations·filing 2007–2025
17Inventor score
Files withJADE BIRD DISPLAY SHANGHAI LTD2TAIBIDI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD2CSPC ZHONGGI PHARMACEUTICAL TECHNOLOGY SHIJIAZHUANG CO LTD1CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD1LI CHUNLEI1
Top patents by PatentIndex Score
8 records- 0168US10028913B2Liposomal pharmaceutical preparation and method for manufacturing the sameCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2016·Granted Jul 24, 2018·1 cites·13 claims
- 0255US2011245334A1Use of racemates of pinocembrin in preparing medicaments for treating strokeCSPC ZHONGGI PHARMACEUTICAL TECHNOLOGY SHIJIAZHUANG CO LTD·Filed 2009·Application pending·0 cites
- 0354US2024374738A1Bifunctional compound capable of degrading receptor tyrosine kinase and application thereofTAIBIDI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2024·Application pending·0 cites
- 0449US2011002977A1Liposomal pharmaceutical preparation and method for manufacturing the sameLI CHUNLEI·Filed 2007·Application pending·0 cites
- 0542US2025274574A1Method and system for correcting nonuniformity of near-eye displayJADE BIRD DISPLAY SHANGHAI LTD·Filed 2025·Application pending·0 cites
- 0641US2024299557A1Compound for degrading deoxyribonucleic acid (dna) polymerase, and use thereofTAIBIDI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2022·Application pending·0 cites
- 0741US2025232714A1Method and system for correcting nonuniformity of near-eye displayJADE BIRD DISPLAY SHANGHAI LTD·Filed 2025·Application pending·0 cites
- 0832US2024270780A1Proteolysis targeting compound with tissue targeting capability and use thereofTAI BI DI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jinxu Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →